Spinal Cord Trauma Treatment Market Expected To Reach US$ 3,036.2 Mn By 2027

“Spinal Cord Trauma Treatment Market: Global Industry Analysis 2012 – 2016 and
Forecast 2017 – 2025” is the recent report of Persistence Market Research that throws
light on the overall market scenario during the period of eight years, i.e. 2017-2025.
According to this report, Global spinal cord trauma treatment market is expected to
witness significant growth during the forecast period. This growth is expected to be
primarily driven by increasing incidence of spinal cord trauma, and increasing
government support to reduce the burden of spinal cord injuries. Additionally,
development of nerve cells growth therapy is expected to boost the market in near
future. The global market for spinal cord trauma treatment is is estimated to be valued
at US$ 2,276.3 Mn in terms of value by the end of 2017. The global spinal cord
trauma treatment market is expected to expand at a CAGR of 3.7% over the forecast
period to reach a value of US$ 3,036.2 Mn by 2027 end.
Request to view table of content @
https://www.persistencemarketresearch.com/toc/17353
On the basis of end user, the global spinal cord trauma treatment market is segmented
into hospitals and trauma centers. Hospitals segment dominated the global spinal cord
trauma treatment market in revenue terms in 2016 and is projected to continue to do
so throughout the forecast period. Hospitals and trauma centers segments are
expected to approximately similar attractive index. Hospitals segment accounted for
53.2% value share in 2017 and is projected to account for 52.5% share by 2025 end.
On the basis of injury type, the global spinal cord trauma treatment market is
segmented into complete spinal cord injuries and partial spinal cord injuries. Partial
spinal cord trauma treatment segment is expected to show better growth than the
completed spinal cord treatment segment due to higher growth in the incidence rate
of partial spinal cord trauma than the complete spinal cord trauma. With US$ 1,870.3
Mn market value in 2025, this segment is likely to expand at CAGR 3.8% throughout
the projected period.
Request Sample Report @
https://www.persistencemarketresearch.com/samples/17353
On the basis of treatment type, the global spinal cord trauma treatment market is
segmented into corticosteroid, surgery, and spinal traction segments. Surgery segment
dominated the global spinal cord trauma treatment market in revenue terms in 2016
and is projected to continue to do so throughout the forecast period. Surgery segment
is the most attractive segment, with attractiveness index of 2.6 over the forecast
period.
This market is segmented into five regions such as North America, Latin America,
Europe, APAC and MEA. Asia-Pacific account for the largest market share in the
global spinal cord trauma treatment market. Large patient population due to the high
rate of road accidents and crime is making the Asia Pacific region most attractive
market for spinal cord trauma treatment. On the other hand, MEA and Latin America
is expected to be the least attractive market for spinal cord trauma treatment, with
attractiveness index of 0.3 and 0.5 respectively over the forecast period.
Acorda Therapeutics, Inc., Asterias Biotherapeutics, ReNetX Bio, BioArctic AB,
BioTime, Inc., InVivo Therapeutics, Kringle Pharma, Inc., Novartis AG, Pfizer Inc.,
Pharmicell Co. Ltd., Vertex Pharmaceuticals Inc., and Bioaxone Biosciences, Inc. are
some of the key players in the global spinal cord trauma treatment market.
Buy Spinal Cord Trauma Treatment Market Report @
https://www.persistencemarketresearch.com/checkout/17353
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com

Spinal cord trauma is generally treated in the emergency unit and specific trauma centers. But in the Middle East & Africa region only a limited number of these centers are available. Lack of availability of proper treatment facility is stalling the growth of the spinal cord trauma treatment market. Person who is suffered with the spinal cord trauma has higher chances of death in African region due to limited access to the emergency healthcare facility.